Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...

Recent advancements in deep learning have transformed the analysis of blood cell images and the classification of leukemia. By employing complex neural network architectures, such as convolutional ...

A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...

The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...

A new treatment option for certain patients with blood cancers has passed muster with the European Commission (EC). Zemcelpro, made by ExCellThera subsidiary Cordex Biologics, is a one-time cell ...

Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic ...